• ARCA Cy3 EGFP mRNA (5-moUTP) Workflow Guide

  2026-08-15

  Build a two-channel assay that separates mRNA uptake from productive translation. This guide shows how to use a fluorescent, capped, modified reporter to optimize mammalian-cell delivery, compare formulations, and troubleshoot endosomal escape.

• EdU Imaging Kits (HF594) for Treg Proliferation

  2026-08-14

  EdU Imaging Kits (HF594) combine S-phase labeling with red-fluorescent click chemistry for sensitive cell proliferation measurements in microscopy and flow cytometry. The workflow is especially useful for separating Treg expansion from differentiation-marker changes in asthma and immunology studies.

• Verteporfin Activates IRE1α to Sensitize Breast Cancer

  2026-08-14

  A 2025 Cell Chemical Biology study identifies verteporfin as a molecular glue-like activator of IRE1α, promoting His692-dependent dimerization, XBP1 splicing, and downstream regulation of PTEN, AKT, and BACH1. The work provides a mechanistic rationale for combining verteporfin with AKT inhibition to suppress breast cancer growth and invasion more effectively than either strategy alone.

• DAF-2 diacetate for NO Imaging in Nodules

  2026-08-13

  DAF-2 diacetate converts intracellular nitric oxide activity into a retained fluorescent signal, supporting live-cell imaging, biochemical assays, and plant nodule research. This workflow connects sensitive NO measurements with the sulfur-dependent control of soybean nodule senescence described in recent Nature Communications research.

• IR-1061: Near Infrared Fluorescent Dye Workflows

  2026-08-13

  IR-1061 supports low-background NIR-II imaging when the dye is freshly prepared and correctly formulated. This guide translates carrier selection, loading control, and assay troubleshooting into practical workflows for deep-tissue, vascular, and other biomedical imaging studies.

• EdU Imaging Kits (Cy3) in Cholangiocarcinoma Research

  2026-08-12

  EdU Imaging Kits (Cy3) convert a short DNA-replication pulse into a bright, quantifiable readout for cholangiocarcinoma cell proliferation. This guide connects the assay to senescence-related biomarker research, drug-response testing, fluorescence imaging, and practical workflow troubleshooting.

• FerroOrange: Live-Cell Fe²⁺ Detection Workflow

  2026-08-12

  FerroOrange converts intracellular Fe²⁺ activity into a fluorescence readout that can be integrated with microscopy, flow cytometry, or plate-based screening. This practical guide connects live-cell assay design with the Cdk5–AMPK–ferroptosis findings reported in ischemic-stroke models, while emphasizing controls, optimization, and interpretation limits.

• BCECF and the Translational Logic of Tissue Acidity

  2026-08-11

  Extracellular acidity is often treated as a background variable, yet it can reshape transporter activity, metabolism, immune-cell behavior, and disease-model interpretation. This thought-leadership article positions BCECF as a practical bridge between mechanistic signaling studies and quantitative microenvironmental pH analysis, using recent neuropathic pain research to define opportunities, limitations, and a translational validation strategy.

• Resazurin Sodium Salt for Cell Viability

  2026-08-11

  Resazurin sodium salt is a fluorogenic oxidation-reduction indicator that converts cellular reducing activity into a resorufin fluorescence signal. Its DMSO solubility, red-fluorescent readout, and compatibility with scalable formats support viability, proliferation, and cytotoxicity workflows when exposure time and concentration are controlled.

• Glutamine Metabolism in HSCs and Liver Fibrosis

  2026-08-10

  The reference study identifies a SIRT4–GDH metabolic axis that sustains glutamine catabolism, energy production, and hepatic stellate cell activation during liver fibrosis. Its combination of pharmacological and genetic evidence suggests that restraining glutamate conversion to α-ketoglutarate may reduce HSC proliferation and fibrosis progression, while also highlighting important limits for translation.

• Ciclesonide: Mechanism and Research Uses

  2026-08-09

  Ciclesonide is a glucocorticoid receptor agonist prodrug that is converted in lung cells to the more potent metabolite desisobutyryl-ciclesonide. Its localized activation, receptor pharmacology, and anti-inflammatory benchmarks support asthma treatment research and allergic rhinitis treatment studies, while its evidence does not establish a role in ERAD-based protein degradation.

• Hoechst 33342 for Fibroblast Senescence Assays

  2026-08-08

  Discover how Hoechst 33342 can serve as more than a nuclear label in dermal fibroblast senescence research. This guide connects live-cell imaging, fixed-cell analysis, and flow cytometry with mitochondrial quality-control readouts inspired by recent pterostilbene research.

• Galectin-1, FIP200, and Hepatic Steatosis

  2026-08-07

  The reference study identifies galectin-1 as an upstream inhibitor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance through direct interaction with FIP200. Its combination of in vivo metabolic phenotyping, proteomic analysis, binding studies, and interaction-disrupting mutations provides a mechanistic framework for studying the Gal-1–FIP200 axis in NAFLD.

• Ultra Fast LC–MS/MS for Cefazedone and Etimicin PK Profiling

  2026-08-07

  The reference study presents a validated ultra fast LC–MS/MS method for simultaneous quantification of cefazedone and etimicin in beagle dog plasma. This innovation enables precise pharmacokinetic profiling of combination antibiotic regimens, supporting safer and more effective dosing strategies for researchers working on β-lactam and aminoglycoside therapies.

• Bazedoxifene: Selective Estrogen Receptor Modulator in Resea

  2026-08-06

  Bazedoxifene stands out as a third-generation selective estrogen receptor modulator, enabling precise control over estrogen signaling in both osteoporosis and cancer research. This article details experimental workflows, advanced applications, and essential troubleshooting strategies that leverage Bazedoxifene’s dual agonist/antagonist profile for robust, reproducible results.

554 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page